Spero Therapeutics, Inc. (SPRO)
1.20
-0.01
(-0.83%)
USD |
NASDAQ |
Aug 28, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Free Cash Flow : 19.58M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.58M |
| March 31, 2026 | 7.242M |
| December 31, 2025 | -12.62M |
| September 30, 2025 | -27.67M |
| June 30, 2025 | -32.33M |
| March 31, 2025 | -33.38M |
| December 31, 2024 | -23.44M |
| September 30, 2024 | -17.54M |
| June 30, 2024 | -14.38M |
| March 31, 2024 | -14.20M |
| December 31, 2023 | -33.00M |
| September 30, 2023 | 28.98M |
| June 30, 2023 | 12.11M |
| March 31, 2023 | 7.639M |
| December 31, 2022 | -7.731M |
| September 30, 2022 | -79.56M |
| Date | Value |
|---|---|
| June 30, 2022 | -83.56M |
| March 31, 2022 | -77.09M |
| December 31, 2021 | -64.35M |
| September 30, 2021 | -53.39M |
| June 30, 2021 | -69.76M |
| March 31, 2021 | -78.10M |
| December 31, 2020 | -86.03M |
| September 30, 2020 | -87.13M |
| June 30, 2020 | -75.49M |
| March 31, 2020 | -62.74M |
| December 31, 2019 | -50.33M |
| September 30, 2019 | -48.76M |
| June 30, 2019 | -42.02M |
| March 31, 2019 | -38.59M |
| December 31, 2018 | -39.62M |
| September 30, 2018 | -38.86M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Inovio Pharmaceuticals, Inc. | -80.78M |
| Fortress Biotech, Inc. | 120.28M |
| Kura Oncology, Inc. | -117.43M |
| Legend Biotech Corp. | -264.16M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.355M |
| Free Cash Flow Per Share (Quarterly) | -0.0924 |
| Free Cash Flow to Equity (Quarterly) | -4.924M |
| Free Cash Flow to Firm (Quarterly) | -5.355M |
| Free Cash Flow Yield | 28.27% |